[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"digital-health-intervention\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:digital-health-intervention":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,49,87,117],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":4},"100641331","digitally-assisted-rehabilitation-at-home-for-older-adults-after-hip-surgery-grimsel-100641331",false,"NCT07658664","Digitally Assisted Rehabilitation at Home for Older Adults After Hip Surgery (GRIMSEL)","Digitally Assisted Geriatric Home-rehabilitation in Older Patients After Hip Surgery (GRIMSEL): a Non-inferiority Randomized Controlled Trial","GRIMSEL","Inclusion Criteria:\n\n* Community-dwelling adults aged 55 to 80 years\n* Hospitalized for hip surgery with unrestricted weight bearing at University Hospital Bern\n\nExclusion Criteria:\n\n* Discharge to inpatient rehabilitation\n* inability to comply with a rehabilitation program (e.g. comorbidity that prevents 30min light workout, major cognitive impairment)\n* end-of life situation","ALL","55 Years","80 Years",{"count":21,"type":22},66,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to learn if a 12-week digitally supported, multimodal home rehabilitation program using the medical application Akina is as effective compared to routine care regarding functional independence in older adults undergoing hip surgery.\n\nHow is this multimodal home rehabilitation program received by patients? Is this multimodal home program at least as effective in terms of functional indpendence, muscle status, mobility and quality of life compared to routine care?\n\nResearchers will compare the multimodal rehabilitation program using the application Akina to routine care to see if the program works to treat patients after hip surgery.\n\nParticipants will:\n\nUndergo the rehab program at home or receive routine care (outpatient physiotherapy) for 12 weeks Visit the clinic after 6 and 12 weeks",[28,29,30,31],"Hip Surgery","Rehabilitation Program","Geriatrics Rehabilitation","Digital Health Intervention",[33,34,35,36],"functional independence","home-based rehabilitation","self-management","orthogeriatrics","NOT_YET_RECRUITING","2026-06-16",{"date":40,"type":41},"2026-06-22","ACTUAL",{"date":43,"type":22},"2026-08",{"date":45,"type":22},"2028-08",{"name":47,"class":48},"Insel Gruppe AG, University Hospital Bern","OTHER",{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":17,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":4,"studyType":23,"phases":61,"briefSummary":62,"conditions":63,"keywords":69,"overallStatus":78,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":79,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":86},"100642005","reward-sensitivity-digital-intervention-for-suicide-risk-100642005","NCT07661901","Reward Sensitivity Digital Intervention for Suicide Risk","Pilot Development of a Youth-Focused Digital Just-in-Time Adaptive Intervention to Enhance Reward Sensitivity and Reduce Suicidal Ideation","DIGIReward","Inclusion Criteria:\n\nADOLESCENTS\n\n* Aged 13-17 years old\n* Recent suicidal ideation\n* Access to a smartphone device\n* Residing in the Philadelphia metropolitan area\n\nLEGALGUARDIANS\n\n* They are the legal guardian of an adolescent that meets all study criteria (see above)\n* They can read, write, and speak English\n\nExclusion Criteria:\n\nADOLESCENTS\n\n* Psychotic disorder, including schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified, with a past year psychotic episode prior to baseline\n* Bipolar disorder I diagnosis, with a past year manic episode prior to baseline\n* Imminent suicide risk (e.g., active suicidal ideation with a specific plan and intent)\n\nLEGALGUARDIANS\n\n\\- There are no exclusion criteria for legal guardians","13 Years","17 Years",{"count":60,"type":22},20,[25],"The goal of this clinical trial is to develop and test an app designed to reduce suicide risk and improve emotional well-being in adolescents. The study will test if the app's daily check ins and recommended mood boosting skills will improve the adolescent's overall mood and suicidality. The main question it aims to answer is:\n\n• Is the app practical and acceptable to use daily?\n\nIn the study, adolescents will:\n\n* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.).\n* Complete surveys and assessments on their mood, thoughts, and experiences.\n* Complete assessments about their app experience.\n\nIn the study, the legal guardian of the adolescent will:\n\n* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.).\n* Complete assessments about their app experience.",[64,65,66,31,67,68],"Suicidal Ideation","Suicidal","Suicidal Thoughts","Reward Sensitivity","Anhedonia",[70,71,72,73,74,75,76,77,67,68],"Adolescents","Legal Guardians","Digital","Philadelphia","Suicide","Intervention","Prevention","Dyads","RECRUITING",{"date":40,"type":41},{"date":81,"type":22},"2026-06",{"date":83,"type":22},"2027-09",{"name":85,"class":48},"University of Pennsylvania",1,{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":11,"sex":17,"minAge":93,"maxAge":4,"enrollmentInfo":94,"targetDuration":4,"studyType":23,"phases":96,"briefSummary":97,"conditions":98,"keywords":101,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":86},"100632311","burden-evaluated-active-therapy-for-af-using-continuous-wearables-beat-af-trial-100632311","NCT07512037","Burden-Evaluated Active Therapy for AF Using Continuous Wearables BEAT-AF Trial","Inclusion Criteria:\n\n* Inpatients ≥18 years of age at admission;\n* Paroxysmal atrial fibrillation was diagnosed;\n* Own a smart phone and a smart watch and be able to operate them basically;\n* Before being enrolled, the average daily atrial fibrillation burden was calculated to be ≥ 4.59% based on monitoring through an intelligent wristwatch for at least 3 days;\n* The treatment status meets any of the following conditions:\n\n  1. If anticoagulation therapy is being administered, the treatment plan must be stable for at least 4 weeks;\n  2. If heart rate or rhythm control medications are being used, the treatment plan must be stable for at least 4 weeks;\n  3. Or no specific rhythm control treatment for atrial fibrillation is being received;\n* Sign the informed consent form\n\nExclusion Criteria:\n\n* Has an implanted pacemaker, implantable cardioverter-defibrillator or cardiac resynchronization therapy device.\n* There may be skin diseases, limb deformities or allergies that prevent the proper wearing of wearable devices on the upper limbs.\n* Having active mental disorders or cognitive impairments, as well as other conditions that result in lack of or restricted ability to act, and which, in the judgment of the researchers, make it impossible for the subject to comply with the trial protocol.\n* During pregnancy, lactation, or planning to become pregnant during the trial period.\n* At the same time, participate in other clinical trials that may interfere with the results of this study","18 Years",{"count":95,"type":22},3194,[25],"Traditional AF classification (e.g., paroxysmal, persistent, permanent) relies largely on patient-reported symptoms and intermittent electrocardiographic monitoring, which cannot continuously or objectively reflect disease progression, nor effectively inform optimal intervention timing. Although \"AF burden\" (i.e., duration of AF episodes) has emerged as a potential marker, its association with clinical outcomes remains inconsistent due to limitations in monitoring methods and its one-dimensional nature. Based on our previous work, investigators developed a five-dimensional AF progression model using photoplethysmography (PPG) signals collected from wearable devices. This model quantifies AF progression across five domains: episode frequency, duration, temporal aggregation, circadian rhythm, and tachycardia burden, enabling continuous and multidimensional assessment. Prior validation has demonstrated high agreement with 24-hour Holter monitoring and effective identification of high-risk patients.\n\nThe BEAT-AF trial is designed to evaluate the clinical utility of this model in a real-world setting. Specifically, investigators will investigate whether early intervention (e.g., optimization of medical therapy or consideration of catheter ablation) in patients with elevated five-dimensional AF burden (≥4.59%) can reduce symptoms, rhythm\u002Frate-related abnormalities, and AF-related adverse events (such as stroke and heart failure). This study is expected to provide new evidence for dynamic monitoring of AF progression, optimal timing of intervention, and personalized management strategies, ultimately improving patient outcomes.",[99,31,100],"Atrial Fibrillation (AF)","Wearable Monitoring",[102,103,104,105,106,107],"Atrial Fibrillation","AF Burden","Wearable Devices","Photoplethysmography (PPG)","Digital Health","Early Intervention","2026-03-30",{"date":110,"type":41},"2026-04-06",{"date":112,"type":22},"2026-04",{"date":114,"type":22},"2029-03",{"name":116,"class":48},"Navy General Hospital, Beijing",{"id":118,"slug":119,"hasResults":11,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":123,"eligibilityCriteria":124,"healthyVolunteers":125,"sex":17,"minAge":126,"maxAge":58,"enrollmentInfo":127,"targetDuration":4,"studyType":23,"phases":129,"briefSummary":130,"conditions":131,"keywords":138,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":86},"100595994","empowering-knowledge-self-testing--resilience-through-innovative-methods-for-hiv-100595994","NCT07039682","Empowering Knowledge, Self-Testing & Resilience Through Innovative Methods for HIV","Developing a Digital-Based Education and Self-Screening Model to Improve Knowledge, Self-Awareness, and HIV Testing Coverage Among Adolescents","EKSTRIM","Inclusion Criteria:\n\n* Adolescents aged 15-17 years\n* Reside or attend school in the Yogyakarta area\n* Currently enrolled in one of the participating high schools\n* Able to read and understand Bahasa Indonesia\n* Own or have regular access to a smartphone or digital device with internet connectivity\n* Provide informed assent to participate in the study\n* Have obtained written parental or guardian consent\n\nExclusion Criteria:\n\n* Adolescents outside the 15-17 age range\n* Unable to access digital devices or internet independently\n* Previously diagnosed with HIV (as this study targets prevention and self-screening among untested adolescents)\n* Unwilling or unable to provide informed assent or whose parents\u002Fguardians do not provide consent\n* Currently participating in another HIV-related intervention study",true,"15 Years",{"count":128,"type":22},400,[25],"The goal of this study is to learn whether a digital tool can help improve HIV knowledge, self-awareness, and testing among adolescents in Yogyakarta, Indonesia. The tool includes online HIV education, a self-assessment for HIV risk, and access to trained peer educators for support. The study will also explore how comfortable and willing adolescents are to use this kind of digital health service.\n\nThe main questions the study aims to answer are:\n\n* Can this digital tool help adolescents better understand HIV and their personal risk?\n* Will more adolescents be willing to get tested for HIV after using the tool?\n* What factors affect whether adolescents accept and use digital HIV services?\n\nResearchers will compare two groups of high school students:\n\n* One group will use the digital tool for 6 weeks\n* The other group will receive standard HIV education (not through the tool)\n\nParticipants will:\n\n* Answer surveys before and after the 6-week period\n* Learn about HIV through videos and interactive content\n* Use the tool to assess their personal HIV risk\n* Receive support from trained peer educators (online)\n\nThe researchers hope this study will lead to new ways of using technology to improve HIV prevention and testing for young people.",[132,133,134,135,31,136,137],"Human Immunodeficiency Virus (HIV) Infection","HIV Prevention","Adolescent Health","Digital Education Interventions","Health Education","HIV Stigma",[139,140,141,142],"hiv prevention","adolescent health","health education","digital intervention","2025-06-18",{"date":145,"type":41},"2025-06-26",{"date":147,"type":22},"2025-07-31",{"date":149,"type":22},"2025-12-31",{"name":151,"class":48},"Universitas Sebelas Maret"]